HIDEFRA Trademark

Trademark Overview


On Friday, October 21, 2022, a trademark application was filed for HIDEFRA with the United States Patent and Trademark Office. The USPTO has given the HIDEFRA trademark a serial number of 79355774. The federal status of this trademark filing is REGISTERED as of Tuesday, May 16, 2023. This trademark is owned by NOVARTIS AG. The HIDEFRA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
hidefra

General Information


Serial Number79355774
Word MarkHIDEFRA
Filing DateFriday, October 21, 2022
Status700 - REGISTERED
Status DateTuesday, May 16, 2023
Registration Number7051345
Registration DateTuesday, May 16, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSandoz AG
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, January 22, 2024CHANGE OF OWNER RECEIVED FROM IB
Tuesday, July 25, 2023NOTIFICATION PROCESSED BY IB
Tuesday, June 27, 2023FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, June 27, 2023FINAL DISPOSITION PROCESSED
Thursday, June 15, 2023GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, May 16, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 16, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2023ASSIGNED TO EXAMINER
Tuesday, December 13, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 13, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, December 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 13, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, December 2, 2022APPLICATION FILING RECEIPT MAILED
Monday, November 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 25, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 17, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB